Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 2, 2007, Pages 199-201

  Coppola, Antonio ^a   Simone, Ciro De ^a   Palmieri, Nicola MacArone ^a   Coppola, Daniela ^a   Lanza, Francesco ^a   Ruosi, Carlo ^a   Amoriello, Aldo ^b   Di Minno, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

Bleeding; Hemostatic agents; Platelet function abnormalities; Recombinant activated factor VII; Storage pool disease; Surgery; Thrombocytopenia with absent radii syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADOLESCENT; ANAMNESIS; ARM; ARM MALFORMATION; ARTICLE; BLEEDING TIME; BOLUS INJECTION; CASE REPORT; FEMALE; HUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURGICAL TECHNIQUE; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTOPENIA; THROMBOCYTOPENIA WITH ABSENT RADII SYNDROME;

ADOLESCENT; BLOOD LOSS, SURGICAL; BLOOD PLATELET DISORDERS; DRUG ADMINISTRATION SCHEDULE; FACTOR VII; FEMALE; HEMOSTASIS; HUMANS; ORTHOPEDIC PROCEDURES; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; TRANEXAMIC ACID;

EID: 33846898969     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3280147fd8     Document Type: Article

References (21)

1. Shaw S, Oliver RAM. Congenital hypoplastic thrombocytopenia with skeletal deformities in siblings. Blood 1959; 14:374-377.
2. Hall JG, Levin J, Kuhn JP, Ottenheimer EJ, van Berkum P, McKusic VA. Thrombocytopenia with absent radius (TAR). Medicine 1969; 48:411-439.
3. Ballmaier M, Schulze H, Strauss G, Cherkaoui K, Wittner N, Lynen S, et al. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood 1997; 90:612-619.
4. Letestu R, Vitrat N, Massé A, Le Coudiac JP, Lazar V, Rameau P, et al. Existence of a differential blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. Blood 2000; 95:1633-1641.
5. Zahavi J, Gale R, Kakkar VV. Storage pool disease of platelets in an infant with thrombocytopenic absent radii (TAR) sindrome simulating Fanconi's anemia. Haemostasis 1981; 10:121-133.
6. Hedberg VA, Lipton JM. Thrombocytopenia with absent radii. A review of 100 cases. Am J Pediatr Hematol Oncol 1988; 10:51-64.
7. Greenhalgh KL, Howell RT, Bottani A, Ancliff PJ, Brunner HG, Verschuuren-Bemelmans CC, et al. Thrombocytopenia-absent radius syndrome: a clinical genetic study. J Med Genet 2002; 39:876-881.
8. Bolan CD, Alving BM. Pharmacologic agents in the management of bleeding disorders. Transfusion 1990; 30:541-551.
9. Coppola A, De Stefano V, Tufano A, Amoriello A, Nardone G, Cerbone AM, Di Minno G. Long-lasting severe intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia. 3-yr pharmacological management. J Int Med 2002; 252:271-275.
10. Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90:2515-2521.
11. Tengborn L, Peturson B. A patient wth Glanzmann's thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thromb Haemost 1996; 75:981-982.
12. Poon M-C, d'Oiron R. Recombinant activated factor VII (NovoSeven®) treatment of platelet-related bleeding disorders. Blood Coagul Fibrinol 2000; 11 (Suppl 1):55-68.
13. Almeida AM, Khair K, Hann I, Liesner R. The use of recombinant factor VIIa in children with inherited platelet function disorders. Br J Haematol 2003; 121:477-481.
14. Poon M-C, d'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, et al., for Members of the International Data Collection on Recombinant FVIIa and Congenital Platelet Disorders Study Group. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. J Thromb Haemost 2004; 2:1096-1103.
15. Rao AK. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 1998; 316:69-76.
16. Monroe DM, Hoffman M, Allen GA, Roberts HR. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost 2000; 26:373-377.
17. Kjalke M, Johannesen M, Hedner U. Effect of recombinant factor VIIa (NovoSeven®) on thrombocytopenia-like conditions in vitro. Semin Hematol 2001; 38 (Suppl 12):15-20.
18. Coppola A, Tufano A, Cimino E, Agangi A, Maruotti GM, Martinelli P, Di Minno G. Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment. Thromb Haemost 2004; 92:1450-1452.
19. Robinson KL, Savoia H, Street AM. Thrombotic complications in two patients receiving NovoSeven® [abstract]. Haemophilia 2000; 6:349.
20. Gabriel DA, Carr M, Roberts HR. Monitoring coagulation and the clinical effects of recombinant Factor VIIa. Semin Hematol 2004; 41 (Suppl 1):20-24.
21. Sørensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements-an update on monitoring haemostatic response using thrombelastography. Haemophilia 2005; 11 (Suppl 1):1-6.